Now... Greater guidance for navigating 5-FU chemotherapy Introducing TheraGuide 5-FU

A test to predict toxicity to 5-FU/capecitabine-based chemotherapy

TheraGuide 5-FU™ is a simple blood test that allows you to customize management and minimize your patients' risk for an adverse reaction to 5-FU-related chemotherapy.

The following presentation was recorded on June 23, 2008. Please fill in the information below to learn about the following topics:

  • Use of pharmacogenetics in understanding patient susceptibility to 5-FU/capecitabine toxicity
  • Toxicity risk associated with variations in DPYD and TYMS
    • DPYD = DPD deficiency
    • TYMS= TS deficiency
  • Use of genetic test results in medical management
Please fill in the following information to view the presentation.
First Name: *
Last Name: *
*
*
Zip Code: *
* denotes required field


* Playback requires Adobe Flash Player.

For more information about TheraGuide 5-FU™, please contact us at 1-800-469-7423 or theraguide@myriad.com.